ROLES OF PHOSPHATIDYLINOSITOL IN THE MECHANISMS INVOLVED IN THE AIRWAY SMOOTH MUSCLE RELAXATION INDUCED BY ATP-SENSITIVE POTASSIUM CHANNEL OPENERS

磷脂酰肌醇在 ATP 敏感钾通道开放剂诱导的气道平滑肌松弛机制中的作用

基本信息

  • 批准号:
    08671750
  • 负责人:
  • 金额:
    $ 1.28万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 财政年份:
    1996
  • 资助国家:
    日本
  • 起止时间:
    1996 至 1997
  • 项目状态:
    已结题

项目摘要

Since K_<ATP> channel openers suppress the airway smooth muscle contraction, they have been investigated for the treatment of bronchial asthma. However, their potencies are different and the mechanisms involved are not fully clarified. Since there is a direct relationship between phosphatidylinositol (PI) response and airway smooth muscle contraction, we examined the effects of Y26763, a novel K_<ATP> channel opener, on PI and contractile responses of rat trachea.The studies were conducted under guidelines approved by the Animal Care Committee. Thirty-six Male Wistar rats weighing 250-350 g were anesthetized with 50 mg/kg intraperitoneal pentobarbital and the trachea was isolated. The trachea was chopped into 3-mm-wide ring segments for the contraction, or chopped into 1-mm-wide slices for PI response with a Mcllwain tissue chopper. First, the trachea rings were suspended between stainless hooks and the resting tension was adjusted to 1.5 g. Active contraction was induced with 0.55 muM Carbachol (CCh) and 30 min later, ring relaxation was induced by stepwise cumulative additions of cromakalim or Y26763. Second, the tracheal slices were incubated with [^3H]myo-inositol and various concentrations of cromakalim or Y26763, and 15 min later the slices were incubated with 0.55 muM CCh for 60 min. The [^3H]inositol monophosphate (IP_1) formed was separated from [^3H]myo-inositol by column chromatography and counted with a liquid scintillation counter. Statistical significance (P <0.05) was determined using ANOVA.CCh-induced tension was attenuated dose-dependently by either cromakalim or Y26763 with a significantly greater potency of Y26763. CCh-induced IP_1 accumulation was potentiated by cromakalim at a dose of 1 muM or greater, but not by Y26763.Results show that Y26763 has a stronger effect on airway smooth muscle relaxation than cromakalim, and suggest that the difference might be accounted in part by the differential effects on PI response.
由于K_ <ATP>频道开启器抑制了气道平滑肌收缩,因此已经对它们进行了调查以治疗支气管哮喘。但是,它们的效力是不同的,涉及的机制尚未完全澄清。由于磷脂酰肌醇(PI)反应与气道平滑肌收缩之间存在直接关系,因此我们检查了Y26763的影响,Y26763是一种新颖的K_ <ATP>启动器,对大鼠气管的PI和收缩反应的影响。根据该指南批准了该研究,该研究得到了动物保健委员会的批准。用50 mg/kg腹膜内五边形的五十六名雄性Wistar大鼠麻醉250-350 g的大鼠,并分离了气管。将气管切成3毫米宽的环段以进行收缩,或切成1毫米宽的切片,并用McLlwain Tissue Chopter将其切成1毫米宽的切片。首先,气管环在不锈钢钩之间悬浮,静止张力调整为1.5 g。用0.55 Mum Carbachol(CCH)诱导活性收缩,30分钟后,Cromakalim或Y26763的逐步累积添加诱导了环松弛。其次,将气管切片与[^3H]肌醇和各种浓度的Cromakalim或Y26763一起孵育,在15分钟后,将切片与0.55 MUM CCH孵育60分钟。形成的[^3H]肌醇单磷酸(IP_1)通过柱色谱法与[^3H]肌醇分离,并用液体闪烁计数器进行计数。使用ANOVA确定统计显着性(p <0.05)。CCH诱导的张力被Cromakalim或Y26763依赖于剂量,其效力明显更高的Y26763。 CCH诱导的IP_1积累以1 MM或更高的剂量增强,但不能通过Y26763进行,结果表明,Y26763比Cromakalim对气道平滑肌松弛的影响更强,并暗示可能由对PI响应的差异效应来解释差异。

项目成果

期刊论文数量(11)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Osamu Shibata: "Contractile and PI responses of rat trachea to anticholinesterase drugs." Can J Anaesth. 45 in press. (1998)
Osamu Shibata:“大鼠气管对抗胆碱酯酶药物的收缩和 PI 反应。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Osamu Shibata: "Anticholinesterase drugs stimulate phosphati-dylinositol response in rat tracheal slices." Anesth Analg. 82. 1211-1214 (1996)
Osamu Shibata:“抗胆碱酯酶药物刺激大鼠气管切片中的磷脂酰肌醇反应。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshiya Tsujita: "Effects of intravenous anesthetics on the contraction and response of rat trachea to PI." Res Commun Mol Path Pharmacol. 95. 287-303 (1997)
Toshiya Tsujita:“静脉麻醉药对大鼠气管收缩和对 PI 反应的影响。”
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Toshya Tsujita: "Efbects of intravenous anesthelics on the contraction and response of rat trachea to phosphatidylinositol" Res Commun Mol path pharmacol. 95. 287-303 (1997)
Toshya Tsujita:“静脉麻醉药对大鼠气管收缩和对磷脂酰肌醇反应的影响”Res Commun Mol path drugl。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Osamu Shibata: "Anticholinesterase drugs stimulate phosphatidylinositol response in rat tracheal slices" Anesth Analg. 82. 1211-1214 (1996)
Osamu Shibata:“抗胆碱酯酶药物刺激大鼠气管切片中的磷脂酰肌醇反应”Anesth Analg。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SHIBATA Osamu其他文献

Phase-Difference Compensation and Nonuniform Pulse Transmission for Accurate Real-Time Moving Object Tracking
用于精确实时移动物体跟踪的相位差补偿和非均匀脉冲传输

SHIBATA Osamu的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SHIBATA Osamu', 18)}}的其他基金

Development of Innovative Targeting Hybrid Artificial Pulmonary Surfactant Preparations by Nanomedicine
纳米医学创新靶向混合人工肺表面活性剂制剂的开发
  • 批准号:
    26350534
  • 财政年份:
    2014
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of Innovative Targeting Artificial pulmonary surfactant preparations by Nanomedicine
纳米医学创新靶向人工肺表面活性物质制剂的开发
  • 批准号:
    23510134
  • 财政年份:
    2011
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Mechanisms of contraction/relaxation of airway smooth muscle : relationship between β-antagonist and Rho-kinase pathway
气道平滑肌收缩/舒张机制:β-拮抗剂与Rho激酶途径的关系
  • 批准号:
    19591804
  • 财政年份:
    2007
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Basic research and development of de novo-designed peptide/fluorinated carbon hybrid artificial lung surfactant
从头设计肽/氟化碳杂化人工肺表面活性剂的基础研究与开发
  • 批准号:
    17310075
  • 财政年份:
    2005
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Mechanisms of airway smooth muscle contraction : physio-pharmacologic factors and intracellular signaling pathway
气道平滑肌收缩机制:生理药理学因素和细胞内信号通路
  • 批准号:
    15591638
  • 财政年份:
    2003
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Effects of Intravenous anesthetics on Phosphatidylinositol Response of Spinal Descending Inhibitory Pathways of Rat
静脉麻醉药对大鼠脊髓下降抑制通路磷脂酰肌醇反应的影响
  • 批准号:
    10671421
  • 财政年份:
    1998
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The Study on Two Dimensional Dynamic Process of Ionic Surfactants Composed of Fluorocarbon and Hydrocarbon Ions
氟碳烃离子组成的离子表面活性剂二维动态过程研究
  • 批准号:
    07672318
  • 财政年份:
    1995
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Estimation of ultraviolet radiation as a limiting factor for vertical distribution of plants by studying their ultraviolet resistance.
通过研究植物的紫外线抵抗力来估计紫外线辐射作为植物垂直分布的限制因素。
  • 批准号:
    02804054
  • 财政年份:
    1990
  • 资助金额:
    $ 1.28万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (C)

相似国自然基金

基于Transgelin-2与RhoA相互作用的针刺抗哮喘舒张气道平滑肌效应机制研究
  • 批准号:
    82374583
  • 批准年份:
    2023
  • 资助金额:
    51 万元
  • 项目类别:
    面上项目
Transgelin-2与Ezrin蛋白结合介导针刺抗哮喘舒张气道平滑肌效应机制研究
  • 批准号:
    82274646
  • 批准年份:
    2022
  • 资助金额:
    52.00 万元
  • 项目类别:
    面上项目
Transgelin-2与Ezrin蛋白结合介导针刺抗哮喘舒张气道平滑肌效应机制研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    52 万元
  • 项目类别:
    面上项目
肠源气道平滑肌解痉物质
  • 批准号:
    82070031
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
肠源气道平滑肌解痉物质
  • 批准号:
  • 批准年份:
    2020
  • 资助金额:
    55 万元
  • 项目类别:
    面上项目

相似海外基金

A Novel Approach to Target Neutrophilic Airway Inflammation and Airway Hyperresponsiveness in Therapy-Resistant (Refractory) Asthma.
一种针对难治性哮喘中性粒细胞性气道炎症和气道高反应性的新方法。
  • 批准号:
    10659658
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Vascular injury and repair predict divergent late onset cardiovascular morbidities after chlorine and sulfur mustard exposure
血管损伤和修复预测氯和硫芥暴露后不同的迟发性心血管疾病
  • 批准号:
    10712025
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Compartmentalized signaling and crosstalk in airway myocytes
气道肌细胞中的区室化信号传导和串扰
  • 批准号:
    10718208
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Defining a type II IL-9R
定义 II 型 IL-9R
  • 批准号:
    10739086
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma.
优化功能选择性 ERK1/2 抑制剂以减少 AP-1 介导的哮喘气道病理。
  • 批准号:
    10666887
  • 财政年份:
    2023
  • 资助金额:
    $ 1.28万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了